Pak J Med Sci19 Feb 2025
Transabdominal ultrasonography (TAUS) shows high compatibility with endoscopic retrograde cholangiopancreatography (ERCP) in diagnosing bile duct obstructive lesions. A retrospective study analyzed patient data and found substantial agreement in identifying conditions such as cholangiocarcinoma, bile duct stricture, and pancreatic cancer, with compatibility rates between 71.4% and…
Hepatobiliary Surg Nutr18 Feb 2025
Significant metabolic alterations and the dynamics of GLP-1 and GLP-2 were identified during liver resection in patients, particularly linking these changes to posthepatectomy liver failure (PHLF). Of the patients studied, metabolic clustering showed that 93% of PHLF individuals fell within one cluster. Preoperative GLP-1 levels…
Hepatology18 Feb 2025
Aptamer-decorated milk-derived nanovesicles (mnvs) effectively targeted cholangiocarcinoma (cca) cells, promoting the delivery of short interfering RNAs (siRNAs) that inhibited key gene expressions. This selective uptake led to reduced tumor growth and increased reactive oxygen species production. Notably, the combined treatment with nanovesicles and chemotherapy showed…
Ann Surg18 Feb 2025
Neoadjuvant therapy changes the prognostic landscape for patients with resected pancreatic ductal adenocarcinoma (PDAC). In a study of 2,760 patients, independent predictors of overall survival (OS) differed significantly: chemotherapy-naïve patients were affected by age, CA19-9 levels, and tumor stage, while neoadjuvant therapy patients faced challenges…
J Gastrointest Surg17 Feb 2025
A novel ALBI-GGT score was developed to enhance prognostic accuracy for patients undergoing hepatocellular carcinoma (HCC) resection. This composite score combines the albumin-bilirubin and gamma-glutamyl transferase metrics, showing superior predictive ability for long-term survival compared to either measure alone. In multivariable analysis, both components significantly…
Eur J Surg Oncol17 Feb 2025
A retrospective cohort study revealed that antiviral therapy (AVT) markedly reduces late recurrence rates in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and compensated cirrhosis post-hepatectomy. The 1-, 3-, 5-, and 10-year recurrence rates for the AVT group were significantly lower than those…
Langenbecks Arch Surg16 Feb 2025
A comprehensive review found that the main pancreatic duct diameter and pancreatic texture are critical for predicting postoperative pancreatic fistula, while age and ASA score are significant for other complications. Of 90 studies evaluated, only 26% of risk stratification tools had external validation, with even…
J Clin Exp Hepatol16 Feb 2025
The ASAP score, evaluated in a cohort of 1,239 patients undergoing hepatic resection for hepatocellular carcinoma (HCC), revealed significant prognostic value. A cutoff of 4.8 classified patients into high and low-risk groups, showing that those with higher scores faced significantly greater 5-year recurrence rates (73.9%…
Front Med (Lausanne)15 Feb 2025
The analysis of 929 articles on necrotizing pancreatitis revealed China as the leading contributor, followed by the United States and India. Notable findings included a focus on minimally invasive treatments, with key publications in specialized journals like "Pancreatology." Despite increased research efforts over the past…
EClinicalMedicine15 Feb 2025
An explainable machine learning model for predicting 90-day mortality in patients with infected pancreatic necrosis (IPN) has shown promising results. The final model, developed from a cohort of 344 patients, achieved a c-index of 0.863 in internal validation and 0.857 in external validation, outperforming nine…